scholarly journals SaO030EFFICACY AND SAFETY OF LOW DOSE VERSUS FULL DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii36-iii36
Author(s):  
Medhat Abdel Halim ◽  
Torki Al-Otaibi ◽  
Osama Gheith ◽  
Hany Adel ◽  
Ahmed Mosaad ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Full Dose

scholarly journals FP865SUCCESSFUL COST EFFECTIVE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS USING LOW DOSE VALGANCICLOVIR

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii366-iii366
Author(s):  
Medhat Halim ◽  
Torki Alotaibi ◽  
Osama Gheith ◽  
Hany Adel ◽  
Ahmed Mosaad ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Cost Effective ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Effective Prevention

scholarly journals MP687SUCCESSFUL COST EFFECTIVE PREVENTION OF CYTOMEGALOVIRUS DISEASE IN KIDNEY TRANSPLANT RECIPIENTS USING LOW DOSE VALGANCICLOVIR

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i568-i568
Author(s):  
Osama Gheith ◽  
Torki Al Otaibi ◽  
Medhat A Halim ◽  
Hany Mansour ◽  
Hany Mansour ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Cost Effective ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Effective Prevention

Short Course of Low Dose Valgancicolvir Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients.

2014 ◽  
Vol 98 ◽  
pp. 259-260
Author(s):  
B. Gopal ◽  
G. Sudhakar ◽  
A. Mohapatra ◽  
A. Abraham ◽  
A. Valson ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cytomegalovirus Disease ◽  
Short Course

scholarly journals MP689EFFICACY AND SAFETY OF LOW DOSE VERSUS HIGH DOSE VALGANCICLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN INTERMEDIATE RISK KIDNEY TRANSPLANT RECIPIENTS

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i568-i569
Author(s):  
Medhat Abdel Halim ◽  
Torki Al-Otaibi ◽  
Osama Gheith ◽  
Hany Adel ◽  
Ahmed Mosaad ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
High Dose ◽  
Intermediate Risk ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cytomegalovirus Disease

CONTROLLED TRIAL OF IL2R ANTIBODY BASILIXIMAB (SIMULECT) VS LOW DOSE OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS.

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S156 ◽  
Author(s):  
Hamid Shidban ◽  
M. Sabawi ◽  
S. Aswad ◽  
G. Chambers ◽  
I. Castillon ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Low Dose ◽  
Controlled Trial ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Cadaver Kidney
Sign in / Sign up

Export Citation Format

Share Document